[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @doepke_michel Michel Doepke Michel Doepke posts on X about $ptgx, $abvx, $jnj, market cap the most. They currently have XXXXX followers and XXX posts still getting attention that total XXXXX engagements in the last XX hours. ### Engagements: XXXXX [#](/creator/twitter::1350720698591936515/interactions)  - X Week XXXXXX -XX% - X Month XXXXXXX -XX% - X Months XXXXXXXXX +69% - X Year XXXXXXXXX +143% ### Mentions: XX [#](/creator/twitter::1350720698591936515/posts_active)  - X Week XXX -XX% - X Month XXX -XX% - X Months XXXXX +46% - X Year XXXXX +153% ### Followers: XXXXX [#](/creator/twitter::1350720698591936515/followers)  - X Week XXXXX +0.71% - X Month XXXXX +3.20% - X Months XXXXX +26% - X Year XXXXX +50% ### CreatorRank: XXXXXXX [#](/creator/twitter::1350720698591936515/influencer_rank)  ### Social Influence **Social category influence** [stocks](/list/stocks) XXXXX% [cryptocurrencies](/list/cryptocurrencies) XXXX% [finance](/list/finance) XXX% [currencies](/list/currencies) XXXX% [countries](/list/countries) XXXX% [travel destinations](/list/travel-destinations) XXXX% **Social topic influence** [$ptgx](/topic/$ptgx) #5, [$abvx](/topic/$abvx) #6, [$jnj](/topic/$jnj) #114, [market cap](/topic/market-cap) #629, [$sny](/topic/$sny) #7, [$nvs](/topic/$nvs) #14, [$nvo](/topic/$nvo) #89, [$lly](/topic/$lly) #71, [$rvmd](/topic/$rvmd) #4, [$arwr](/topic/$arwr) #10 **Top accounts mentioned or mentioned by** [@aggregategains](/creator/undefined) [@biohazard3737](/creator/undefined) [@bionavgator](/creator/undefined) [@midwit_capital](/creator/undefined) [@wallstsai](/creator/undefined) [@semodough](/creator/undefined) [@amaymd](/creator/undefined) [@damiangarde](/creator/undefined) [@persimmonti](/creator/undefined) [@protagonisttxs](/creator/undefined) [@aktionaer](/creator/undefined) [@reddit](/creator/undefined) [@valuedig](/creator/undefined) [@biopharmiq](/creator/undefined) [@macrovet888](/creator/undefined) [@biotechvantage](/creator/undefined) [@maximizebelief2](/creator/undefined) [@mugsley](/creator/undefined) [@meadowcapital](/creator/undefined) [@sanityninsanity](/creator/undefined) **Top assets mentioned** [Protagonist Therapeutics, Inc (PTGX)](/topic/$ptgx) [Johnson & Johnson (JNJ)](/topic/$jnj) [Synthetify (SNY)](/topic/$sny) [Novartis AG (NVS)](/topic/$nvs) [Novo-Nordisk (NVO)](/topic/$nvo) [Eli Lilly and Company (LLY)](/topic/$lly) [Revolution Medicines, Inc. Common Stock (RVMD)](/topic/$rvmd) [Arrowhead Research Corporation (ARWR)](/topic/$arwr) [AbbVie Inc (ABBV)](/topic/$abbv) [Crinetics Pharmaceuticals, Inc. (CRNX)](/topic/$crnx) [Vertex Protocol (VRTX)](/topic/$vrtx) [Blueprint Medicines Corporation (BPMC)](/topic/$bpmc) [Kymera Therapeutics, Inc. Common Stock (KYMR)](/topic/$kymr) [Celldex Therapeutics, Inc (CLDX)](/topic/$cldx) [Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) [Regeneron Pharmaceuticals Inc (REGN)](/topic/$regn) [Cogent Biosciences, Inc. Common Stock (COGT)](/topic/$cogt) [Viking Therapeutics, Inc (VKTX)](/topic/$vktx) [Bristol-Myers Squibb Co (BMY)](/topic/$bmy) [Merck & Co., Inc. (MRK)](/topic/$mrk) [Alpine Immune Sciences, Inc. Common Stock (ALPN)](/topic/$alpn) [Seagen Inc (SGEN)](/topic/$sgen) [Array Technologies, Inc. Common Stock (ARRY)](/topic/$arry) [Metsera, Inc. Common Stock (MTSR)](/topic/$mtsr) [Pfizer, Inc. (PFE)](/topic/$pfe) [Summit Therapeutics Inc. Common Stock (SMMT)](/topic/$smmt) [AstraZeneca PLC (AZN)](/topic/$azn) [Biogen Inc (BIIB)](/topic/$biib) [Madrigal Pharmaceuticals, Inc. Common Stock (MDGL)](/topic/$mdgl) [Insmed, Inc. (INSM)](/topic/$insm) [GRAIL, Inc. Common Stock (GRAL)](/topic/$gral) [GSK plc (GSK)](/topic/$gsk) [IDEAYA Biosciences, Inc. Common Stock (IDYA)](/topic/$idya) [MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX)](/topic/$mltx) [One Cash (ONC)](/topic/$onc) [Axsome Therapeutics, Inc (AXSM)](/topic/$axsm) [United Community Banks, Inc. (UCB)](/topic/$ucb) [Prometheus Biosciences, Inc. Common Stock (RXDX)](/topic/$rxdx) [Wave Life Sciences Ltd. Ordinary Shares (WVE)](/topic/$wve) [Royalty Pharma plc Class A Ordinary Shares (RPRX)](/topic/$rprx) [Neurocrine Biosciences, Inc. (NBIX)](/topic/$nbix) [Biohaven Pharmaceutical Holding Company Ltd. (BHVN)](/topic/$bhvn) [Sanofi (SNY)](/topic/sanofi) [Rhythm Pharmaceuticals, Inc. Common Stock (RYTM)](/topic/$rytm) [Celcuity Inc. Common Stock (CELC)](/topic/$celc) [Baklava (BAVA)](/topic/$bava) ### Top Social Posts Top posts by engagements in the last XX hours "$NBIX Reports Third Quarter 2025 Financial Results. CRENESSITY (crinecerfont) Third-Quarter 2025 Net Product Sales of $98M" [X Link](https://x.com/doepke_michel/status/1983265155707478079) 2025-10-28T20:10Z 5924 followers, 1209 engagements "$VRTX $ALPN Presents Updated Phase 1/2 Data From RUBY-3 Study That Continue to Demonstrate Best-in-Class Potential for Povetacicept in Adults with IgA Nephropathy and Primary Membranous Nephropathy at ASN Kidney Week. $NVS #Otsuka" [X Link](https://x.com/doepke_michel/status/1987474050927472995) 2025-11-09T10:55Z 5924 followers, 5624 engagements "$SGEN ($43B) $ARNA ($7B) $GBT ($5B) $ARRY ($11B) $MTSR ($8B upfront) $TRIL ($2B) $MDVN ($14B) $BHVN ($12B) = $102B. $PFE market cap: $144B" [X Link](https://x.com/doepke_michel/status/1990803460783288528) 2025-11-18T15:25Z 5924 followers, 131.2K engagements "$BPMC a $SNY Company Highlights Long-Term Clinical Benefit of AYVAKIT (avapritinib) Across Indolent and Advanced Systemic Mastocytosis at 2025 ASH Annual Meeting. $COGT" [X Link](https://x.com/doepke_michel/status/1996929129669624106) 2025-12-05T13:06Z 5922 followers, 4379 engagements "$SMMT $500M PIPE @ $18.74$ per share. $AZN Summit Co-CEO and Executive Chairman Robert Duggan Co-CEO and President Mahkam Zanganeh CFO and COO Manmeet Soni CAO Bhaskar Anand and certain non-executive employees invested $272M; Akeso invested $10M remaining $218M raised with multiple leading biopharma institutional investors and other institutional investors" [X Link](https://x.com/doepke_michel/status/1980973417818910972) 2025-10-22T12:24Z 5922 followers, 9023 engagements "#Eisai Submits New Drug Application for Subcutaneous Formulation of Leqembi for the Treatment of Early Alzheimers Disease in Japan. $BIIB $BIOA.ST" [X Link](https://x.com/doepke_michel/status/1994302384391020941) 2025-11-28T07:08Z 5922 followers, 1862 engagements "Exclusive: I met Jennifer Ruddock CBO of $NKTR at BIO Europe in Vienna. Read the interview (Part 1) 👇 $LLY" [X Link](https://x.com/doepke_michel/status/1995059367524315634) 2025-11-30T09:16Z 5922 followers, 9472 engagements "$SGMO Receives U.S. FDA Fast Track Designation for ST-503 for the Treatment of Small Fiber Neuropathy" [X Link](https://x.com/doepke_michel/status/1995843375569011056) 2025-12-02T13:11Z 5924 followers, 2258 engagements "Baker Bros are not always right but I consider them to be among the top investors in the biotech scene. Many very successful stocks and M&A candidates with high weighting. 👇 $MDGL $INSM $RYTM $RVMD $CELC $GRAL $ABVX $ARWR" [X Link](https://x.com/doepke_michel/status/1996514558140420440) 2025-12-04T09:38Z 5922 followers, 7324 engagements "$GSK GSK terminates collaboration agreement with $IDYA" [X Link](https://x.com/doepke_michel/status/1997198425603858615) 2025-12-06T06:56Z 5922 followers, 8522 engagements "$COGT Presents Full SUMMIT Results ofBezuclastinibinPatientswithNonAdvancedSystemic Mastocytosis (NonAdvSM)at the67thAnnual Meeting of the American Society of Hematology (ASH) $BPMC $SNY" [X Link](https://x.com/doepke_michel/status/1997365499621957874) 2025-12-06T18:00Z 5922 followers, 8584 engagements "$GUBRA #BoehringerIngelheim advances next generation triple-agonist peptide for the treatment of obesity into mid-stage development. $LLY $NVO $VKTX $ABBV" [X Link](https://x.com/doepke_michel/status/1997925588753928604) 2025-12-08T07:05Z 5922 followers, 1344 engagements "$TSHA Regains Full Rights to Lead TSHA-102 Program in Clinical Evaluation for the Treatment of Rett Syndrome. #Astellas" [X Link](https://x.com/doepke_michel/status/1978914838500737034) 2025-10-16T20:03Z 5924 followers, 11.9K engagements "$GALD #Galderma Delivers Record Net Sales of XXXXX Billion USD in the First Nine Months of 2025 and XXXX% Year-on-Year Growth at Constant Currency Raises Full-Year Guidance" [X Link](https://x.com/doepke_michel/status/1981225207084761385) 2025-10-23T05:04Z 5924 followers, 1070 engagements "$KYMR Presents New Preclinical Data for KT-579 a First-in-Class Oral IRF5 Degrader at the American College of Rheumatology Annual Meeting" [X Link](https://x.com/doepke_michel/status/1982764831460790499) 2025-10-27T11:02Z 5924 followers, 4515 engagements "$KYTX nnounces Positive Interim Phase X Data from KYSA-6 Study of KYV-101 in Generalized Myasthenia Gravis at AANEM 2025. $ARGX $JNJ" [X Link](https://x.com/doepke_michel/status/1983482217298006450) 2025-10-29T10:33Z 5924 followers, 1051 engagements "$BAVA $BAVA.CO Bavarian Nordic Awarded New Procurement Framework Contract by the European Commission to Strengthen Preparedness Against Smallpox and Mpox" [X Link](https://x.com/doepke_michel/status/1984179393900728747) 2025-10-31T08:43Z 5923 followers, 1006 engagements "$SNY Q3 call transcript $ABVX" [X Link](https://x.com/doepke_michel/status/1984198881262088577) 2025-10-31T10:00Z 5920 followers, 10.5K engagements "$SMMT Akeso's Ivonescimab Secures Fourth Breakthrough Therapy Designation in China for First-Line Treatment of Triple-Negative Breast Cancer" [X Link](https://x.com/doepke_michel/status/1985230900939120854) 2025-11-03T06:21Z 5923 followers, 1972 engagements "#Sandoz boosts in-house biosimilars capabilities by signing agreement to acquire Just-Evotec Biologics EU SAS in Toulouse. Transaction includes $350M in cash and upfront license fees. JEB partnered projects below. $SDZ $EVT" [X Link](https://x.com/doepke_michel/status/1985965483959447807) 2025-11-05T07:00Z 5923 followers, 1131 engagements "$MLTX Reports Third Quarter 2025 Financial Results and Announces New Data from Clinical Trials of its Nanobody Sonelokimab" [X Link](https://x.com/doepke_michel/status/1986042879622447171) 2025-11-05T12:08Z 5920 followers, XXX engagements "$CAI Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance" [X Link](https://x.com/doepke_michel/status/1986178318530752875) 2025-11-05T21:06Z 5924 followers, 1255 engagements "$ONC Q3 results. Third quarter total revenues increased XX% to $1.4B" [X Link](https://x.com/doepke_michel/status/1986388946298020304) 2025-11-06T11:03Z 5921 followers, 1058 engagements "$AXSM Acquires Subtype Selective GABA-A Receptor Positive Allosteric Modulator AZD7325 for the Treatment of Epilepsy" [X Link](https://x.com/doepke_michel/status/1986406423333413211) 2025-11-06T12:12Z 5920 followers, 1716 engagements "$PTGX PN-881 entered the clinical stage. First human subject dosed in a Phase X trial in October" [X Link](https://x.com/doepke_michel/status/1986737236524605579) 2025-11-07T10:07Z 5923 followers, 3308 engagements "$CRNX pipeline. $1.1B Cash Balance Funds Current Operating Plan into 2029. Market cap: $4B. The focus is now on the commercial roll-out of Palsonify. $CAMX" [X Link](https://x.com/doepke_michel/status/1986739556469662007) 2025-11-07T10:16Z 5924 followers, 8986 engagements "@PersimmonTI @Biohazard3737 Winning overpriced M&A transactions. $GBT $TRIL $ARNA $SGEN $ARRY" [X Link](https://x.com/doepke_michel/status/1987199579549310987) 2025-11-08T16:44Z 5922 followers, XXX engagements "An approval for Povetacicept (formerly ALPN-303) would also be a success for German based #Evotec. They have a multi-year partnership with $ALPN which was acquired by $VRTX for $4.9B in 2024" [X Link](https://x.com/doepke_michel/status/1987486592567537810) 2025-11-09T11:45Z 5923 followers, 3962 engagements "$COGT Reports Positive Results from Bezuclastinib PEAK Phase X Trial in Gastrointestinal Stromal Tumors (GIST). $BPMC $SNY $DCPH" [X Link](https://x.com/doepke_michel/status/1987853240554381654) 2025-11-10T12:01Z 5922 followers, 17.3K engagements "$IFRX Reports Positive Phase 2a Data for INF904 in Hidradenitis Suppurative (HS) and Chronic Spontaneous Urticaria (CSU). $UCB $MLTX $CLDX" [X Link](https://x.com/doepke_michel/status/1987860888188027283) 2025-11-10T12:32Z 5920 followers, 1554 engagements "$CYTK Presents Additional Data from MAPLE-HCM at the Hypertrophic Cardiomyopathy Medical Society Scientific Sessions and American Heart Association Scientific Sessions 2025. $BMY" [X Link](https://x.com/doepke_michel/status/1987861071080640647) 2025-11-10T12:33Z 5921 followers, 7125 engagements "$RLMD should receive more attention here. Small position. $ENGN $CGON" [X Link](https://x.com/doepke_michel/status/1988259990444904910) 2025-11-11T14:58Z 5924 followers, 7674 engagements "$EVT #Evotecreceives milestone payment from $BMY Bristol Myers Squibb following IND acceptance in strategic protein degradation partnership. $5M to Evotec" [X Link](https://x.com/doepke_michel/status/1988497869066707257) 2025-11-12T06:43Z 5923 followers, 1251 engagements "$LEGN Q3 results. Carvykti net trade sales of approximately $524M. $JNJ" [X Link](https://x.com/doepke_michel/status/1988578766181056732) 2025-11-12T12:04Z 5924 followers, XXX engagements "$ZEAL Announces Financial Results for the First Nine Months of 2025. 2.2B cash" [X Link](https://x.com/doepke_michel/status/1988861762179850693) 2025-11-13T06:49Z 5923 followers, 3047 engagements "$DAWN to Acquire $MRSN - $XX per share + CVR" [X Link](https://x.com/doepke_michel/status/1988954785614295455) 2025-11-13T12:59Z 5924 followers, 1169 engagements "$ONC Positive Phase X Results Support ZIIHERA as HER2-Targeted Therapy-of-Choice and Combination with TEVIMBRA and Chemotherapy as New Standard of Care in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma $JAZZ $ZYME" [X Link](https://x.com/doepke_michel/status/1990375217924100198) 2025-11-17T11:03Z 5924 followers, 3305 engagements "$MRUS and $HALO Enter Global Collaboration and License Agreement to Develop Subcutaneous Formulation of Petosemtamab" [X Link](https://x.com/doepke_michel/status/1990399722624823403) 2025-11-17T12:40Z 5921 followers, 1678 engagements "$ABVX now $9B market cap after successful UC phase X. Keep in mind: $MRK acquired $RXDX for $10.8B after a successful phase 2" [X Link](https://x.com/doepke_michel/status/1990430862542795260) 2025-11-17T14:44Z 5921 followers, 15.9K engagements "$PTGX $JNJ $TAK" [X Link](https://x.com/doepke_michel/status/1990766009113055694) 2025-11-18T12:56Z 5921 followers, 3696 engagements "$NUVL Announces Pricing of Public Offering of Common Stock - $XXXXXX per share" [X Link](https://x.com/doepke_michel/status/1991026317186511112) 2025-11-19T06:10Z 5921 followers, XXX engagements "$ARWR the US approval of REDEMPLO is just the beginning. XX clinical stage programs (10 wholly-owned; X partnered) - more to come. Strong comeback: share price has quadrupled from its low for the year. $NVS $SRPT $AMGN $GSK $TAK" [X Link](https://x.com/doepke_michel/status/1991066965830459719) 2025-11-19T08:52Z 5923 followers, 5799 engagements "$AGIO Announces Topline Results from RISE UP Phase X Trial of Mitapivat in Sickle Cell Disease. $CRSP $VRTX" [X Link](https://x.com/doepke_michel/status/1991115109171863846) 2025-11-19T12:03Z 5924 followers, 3201 engagements "$RNA Announces U.S. Managed Access Program (MAP) for Investigational Therapy del-zota in DMD44. $NVS $SRPT" [X Link](https://x.com/doepke_michel/status/1991149012368380290) 2025-11-19T14:18Z 5924 followers, 2654 engagements "$ABVX $10B now. Keep in mind: $MRK paid for $RXDX $10.8B after a successful phase 2" [X Link](https://x.com/doepke_michel/status/1991545937106452513) 2025-11-20T16:35Z 5921 followers, 5989 engagements "$CRNX Announces First Patient Randomized in Pivotal Phase X CAREFNDR Trial Evaluating Paltusotine in Carcinoid Syndrome" [X Link](https://x.com/doepke_michel/status/1991763374259224615) 2025-11-21T06:59Z 5922 followers, 1288 engagements "$GEHC to acquire Intelerad advancing cloud-enabled enterprise imaging across care settings for $2.3B. #Sectra $SECTRA" [X Link](https://x.com/doepke_michel/status/1991777630153249146) 2025-11-21T07:56Z 5923 followers, 1234 engagements "$VSTM upcoming catalysts. Impressive strength after the latest offering last week ($90M at $XXXX per share). $XX area key resistance. $RVMD" [X Link](https://x.com/doepke_michel/status/1991828416073748609) 2025-11-21T11:17Z 5923 followers, 4523 engagements "$ARWR Earns $XXX Million Milestone Payment from $SRPT" [X Link](https://x.com/doepke_michel/status/1992953114362888385) 2025-11-24T13:47Z 5923 followers, 5987 engagements "$BIIB and Dayra Therapeutics Announce Research Collaboration to Discover and Develop Oral Macrocyclic Peptides for a Range of Immunological Conditions" [X Link](https://x.com/doepke_michel/status/1992990024355184814) 2025-11-24T16:13Z 5923 followers, 1415 engagements "$REGN $SNY Dupixent (dupilumab) Approved as the First Targeted Medicine in the European Union (EU) in Over a Decade for Chronic Spontaneous Urticaria (CSU). $CLDX" [X Link](https://x.com/doepke_michel/status/1993209633776058880) 2025-11-25T06:46Z 5923 followers, 12.2K engagements "$ABVX $RVMD $PTGX trading like a buyout announcement is imminent. Incredible strength" [X Link](https://x.com/doepke_michel/status/1993630538427744637) 2025-11-26T10:38Z 5923 followers, 7577 engagements "#Otsuka Receives FDA Accelerated Approval for VOYXACT (sibeprenlimab-szsi) for the Reduction of Proteinuria in Adults with Primary Immunoglobulin A Nephropathy (IgAN) at Risk for Disease Progression. $VRTX $NVS $TVTX" [X Link](https://x.com/doepke_michel/status/1993651846406340989) 2025-11-26T12:03Z 5922 followers, 1404 engagements "$ARWR patience pays off. What an impressive recovery from $XX - the stock was my favorite for the year 2025" [X Link](https://x.com/doepke_michel/status/1993659637430931699) 2025-11-26T12:34Z 5921 followers, 4076 engagements "$ARWR $XX. As I wrote at the end of 2024: 2025 is a year with many interesting inflection points + unlocking obesity fantasy/potential" [X Link](https://x.com/doepke_michel/status/1993710310742773857) 2025-11-26T15:55Z 5923 followers, 6910 engagements "$MDGL $XXX 💥" [X Link](https://x.com/doepke_michel/status/1993724214269116631) 2025-11-26T16:51Z 5920 followers, XXX engagements "$VSTM $XXXXX - strength continues after the offering. $RVMD" [X Link](https://x.com/doepke_michel/status/1993759421797630008) 2025-11-26T19:11Z 5923 followers, 2157 engagements "From injections to pills: oral peptides set to transform drug development (August 2025). $PTGX $JNJ $MRK" [X Link](https://x.com/doepke_michel/status/1993976464010826030) 2025-11-27T09:33Z 5923 followers, 4047 engagements "$PTGX TD Cowen Advancements in #Obesity Summit. Some interesting comments. $LLY $NVO" [X Link](https://x.com/doepke_michel/status/1994058904561471588) 2025-11-27T15:01Z 5921 followers, 3316 engagements "$ABBV SKYRIZI (risankizumab) Receives Positive Reimbursement Recommendation by Canadas Drug Agency for Ulcerative Colitis and AbbVie Concludes Letter of Intent with the pan-Canadian Pharmaceutical Alliance" [X Link](https://x.com/doepke_michel/status/1994378403345203589) 2025-11-28T12:10Z 5923 followers, 1231 engagements "$IONS receives U.S. FDA Breakthrough Therapy designation for olezarsen for severe hypertriglyceridemia (sHTG)" [X Link](https://x.com/doepke_michel/status/1995463172921102388) 2025-12-01T12:01Z 5921 followers, 1805 engagements "$REGN and Tessera Therapeutics to Jointly Develop TSRA-196 an Investigational Gene Editing Therapy for Alpha-1 Antitrypsin Deficiency (#AATD)" [X Link](https://x.com/doepke_michel/status/1995463329356173364) 2025-12-01T12:01Z 5923 followers, 1264 engagements "$LLY lowers the price of Zepbound (tirzepatide) single-dose vials. $NVO" [X Link](https://x.com/doepke_michel/status/1995486133610856902) 2025-12-01T13:32Z 5923 followers, 2217 engagements "$AZN #Astrazeneca Baxdrostat New Drug Application accepted under FDA Priority Review in the US for patients with hard-to-control hypertension. PDUFA date is anticipated during the second quarter of 2026 following use of a Priority Review voucher. $MLYS" [X Link](https://x.com/doepke_michel/status/1995767314541646171) 2025-12-02T08:09Z 5924 followers, 1486 engagements "$VTYX Provides Clinical and Corporate Updates" [X Link](https://x.com/doepke_michel/status/1995826196383191048) 2025-12-02T12:03Z 5922 followers, 1538 engagements "$CLDX strength up X% after $JSPR asthma data" [X Link](https://x.com/doepke_michel/status/1995903104068223261) 2025-12-02T17:09Z 5922 followers, 2193 engagements "$PHVS $RPRX" [X Link](https://x.com/doepke_michel/status/1996187140422857029) 2025-12-03T11:57Z 5923 followers, 1764 engagements "After $JNJ and $NVO failures: $BMY Announces Continuation of ADEPT-2 Phase X Study in Psychosis Associated with Alzheimer's Disease" [X Link](https://x.com/doepke_michel/status/1996189893672710624) 2025-12-03T12:08Z 5922 followers, 4164 engagements "$CRNX next step 👍" [X Link](https://x.com/doepke_michel/status/1996205752441274743) 2025-12-03T13:11Z 5922 followers, 2279 engagements "$CRNX break. Next target $60" [X Link](https://x.com/doepke_michel/status/1996238654465880385) 2025-12-03T15:22Z 5922 followers, 1979 engagements "Interesting. $ABBV already partnered with $GUBRA (amylin) this year. Who's next $LLY $NVO $VKTX $GPCR" [X Link](https://x.com/doepke_michel/status/1996259143653458089) 2025-12-03T16:44Z 5923 followers, 7130 engagements "$DNLI and $RPRX Announce $XXX Million Royalty Funding Agreement" [X Link](https://x.com/doepke_michel/status/1996550722142531827) 2025-12-04T12:02Z 5924 followers, 4395 engagements "What else can $ABBV say Rinvoq and Skyrizi are THE growth drivers in the portfolio following the Humira patent cliff. Competition is not welcome here - I can imagine that AbbVie will purchase/license further assets in this area and in the field of obesity. $ABVX $GUBRA" [X Link](https://x.com/doepke_michel/status/1996592436798177628) 2025-12-04T14:48Z 5923 followers, 2874 engagements "$PRAX Announces Positive Pre-NDA Meeting with FDA for Ulixacaltamide in Essential Tremor" [X Link](https://x.com/doepke_michel/status/1996687174943789298) 2025-12-04T21:04Z 5921 followers, 2052 engagements "IDE034 a Bispecific #ADC Licensed by Biocytogen to $IDYA Receives FDA IND Clearance" [X Link](https://x.com/doepke_michel/status/1996839438018863344) 2025-12-05T07:09Z 5922 followers, 1201 engagements "$NTRA Acquires #Foresight Diagnostics - all-stock transaction consisting of a $XXX million upfront with an additional $XXX million in earnouts tied to the achievement of revenue- and reimbursement-based milestones" [X Link](https://x.com/doepke_michel/status/1996914590115156429) 2025-12-05T12:08Z 5923 followers, 1688 engagements "$VKTX interesting price action yesterday. New FDA guidelines could make an additional phase X for VK2735 obsolete. The stock must break through the $XX area. Then there is plenty of room for more gains" [X Link](https://x.com/doepke_michel/status/1996920762603565293) 2025-12-05T12:33Z 5923 followers, 8733 engagements "$CLDX 52-week high yesterday. The bulls are finally waking up. 2026 will be an extremely important year for Celldex. Small position" [X Link](https://x.com/doepke_michel/status/1996922027513729225) 2025-12-05T12:38Z 5922 followers, XXX engagements "The "robots are on the move" see $IRBT. I'm wondering why $BB hasn't jumped yet. But it could still happen. Current share price: $XXXX #QNX #Robotics @Reddit" [X Link](https://x.com/doepke_michel/status/1996938970396348619) 2025-12-05T13:45Z 5924 followers, 1868 engagements "$PTGX strength into the weekend. Deal close $JNJ $TAK" [X Link](https://x.com/doepke_michel/status/1997033377338466753) 2025-12-05T20:00Z 5924 followers, 2856 engagements "OSE Immunotherapeutics Announces Strategic Amendment to AbbVies Partnership on ABBV-230 Development. $ABBV" [X Link](https://x.com/doepke_michel/status/1997917855132885316) 2025-12-08T06:35Z 5923 followers, 1389 engagements "$AXSM new ATH - interesting potential buyout target. $BPMC $ITCI $VRNA and $SWTX gone (see list below)" [X Link](https://x.com/doepke_michel/status/1988631039414043064) 2025-11-12T15:32Z 5924 followers, 3886 engagements "What would $PTGX be worth if Icotrokinra and Rusfertide weren't partnered In my opinion $PTGX could be in the range of $INSM in terms of market cap in some years. Large markets ingenious technology (oral). What pharma wants - easily available" [X Link](https://x.com/doepke_michel/status/1991507308107493461) 2025-11-20T14:01Z 5922 followers, 8584 engagements "$KYMR data in December. Barclays comment below. $NKTR $REGN $SNY $CRVS" [X Link](https://x.com/doepke_michel/status/1995385721541235196) 2025-12-01T06:53Z 5924 followers, 4925 engagements "$CRVS additional data in January Barclays comment below. $NKTR $KYMR $SNY $REGN" [X Link](https://x.com/doepke_michel/status/1995385836947509424) 2025-12-01T06:53Z 5923 followers, 8298 engagements "$CAPR Announces Positive Topline Results from Pivotal Phase X HOPE-3 Study of Deramiocel in Duchenne Muscular Dystrophy. $SRPT" [X Link](https://x.com/doepke_michel/status/1996196843303354432) 2025-12-03T12:36Z 5924 followers, 2661 engagements "$PTGX and $TAK Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera" [X Link](https://x.com/doepke_michel/status/1997364426320531937) 2025-12-06T17:56Z 5922 followers, 1448 engagements "$GPCR $WVE $KYMR and $DYN data ahead - busy #biotech Monday. Maybe also a M&A deal $PTGX $RVMD $ABVX" [X Link](https://x.com/doepke_michel/status/1997937248822845835) 2025-12-08T07:52Z 5922 followers, 7804 engagements "$PCSC Freenome and Perceptive Capital Solutions Corp Announce Business Combination Agreement to Create a Publicly Listed Company Transforming Blood-Based Multi-Cancer Detection through an AI/ML-Enabled Multiomics Platform. $GRAL $ILMN $EXAS" [X Link](https://x.com/doepke_michel/status/1996940950199804286) 2025-12-05T13:53Z 5922 followers, 2181 engagements "$GMAB Announces Data From Multiple Clinical Trials Showing Treatment with Fixed-Duration Epcoritamab Led to Remissions in First-Line Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL)" [X Link](https://x.com/doepke_michel/status/1997364848733106487) 2025-12-06T17:57Z 5924 followers, 2379 engagements "$ZLAB Announces Updates to Chinas National Reimbursement Drug List" [X Link](https://x.com/doepke_michel/status/1997606381965434931) 2025-12-07T09:57Z 5922 followers, 1533 engagements "Wow: LORAL GROUPE TO REINFORCE ITS STRATEGIC INVESTMENT IN #GALDERMA WITH AN ADDITIONAL XX% BRINGING ITS TOTAL PARTICIPATION TO 20%" [X Link](https://x.com/doepke_michel/status/1997918197249401310) 2025-12-08T06:36Z 5922 followers, 3141 engagements "Greetings from #DisneylandParis - I hope for a French #biotech buyout soon 😉 Strong day for $ABVX 💪" [X Link](https://x.com/doepke_michel/status/1998518965837115461) 2025-12-09T22:23Z 5922 followers, 2563 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@doepke_michel Michel DoepkeMichel Doepke posts on X about $ptgx, $abvx, $jnj, market cap the most. They currently have XXXXX followers and XXX posts still getting attention that total XXXXX engagements in the last XX hours.
Social category influence stocks XXXXX% cryptocurrencies XXXX% finance XXX% currencies XXXX% countries XXXX% travel destinations XXXX%
Social topic influence $ptgx #5, $abvx #6, $jnj #114, market cap #629, $sny #7, $nvs #14, $nvo #89, $lly #71, $rvmd #4, $arwr #10
Top accounts mentioned or mentioned by @aggregategains @biohazard3737 @bionavgator @midwit_capital @wallstsai @semodough @amaymd @damiangarde @persimmonti @protagonisttxs @aktionaer @reddit @valuedig @biopharmiq @macrovet888 @biotechvantage @maximizebelief2 @mugsley @meadowcapital @sanityninsanity
Top assets mentioned Protagonist Therapeutics, Inc (PTGX) Johnson & Johnson (JNJ) Synthetify (SNY) Novartis AG (NVS) Novo-Nordisk (NVO) Eli Lilly and Company (LLY) Revolution Medicines, Inc. Common Stock (RVMD) Arrowhead Research Corporation (ARWR) AbbVie Inc (ABBV) Crinetics Pharmaceuticals, Inc. (CRNX) Vertex Protocol (VRTX) Blueprint Medicines Corporation (BPMC) Kymera Therapeutics, Inc. Common Stock (KYMR) Celldex Therapeutics, Inc (CLDX) Sarepta Therapeutics, Inc. (SRPT) Regeneron Pharmaceuticals Inc (REGN) Cogent Biosciences, Inc. Common Stock (COGT) Viking Therapeutics, Inc (VKTX) Bristol-Myers Squibb Co (BMY) Merck & Co., Inc. (MRK) Alpine Immune Sciences, Inc. Common Stock (ALPN) Seagen Inc (SGEN) Array Technologies, Inc. Common Stock (ARRY) Metsera, Inc. Common Stock (MTSR) Pfizer, Inc. (PFE) Summit Therapeutics Inc. Common Stock (SMMT) AstraZeneca PLC (AZN) Biogen Inc (BIIB) Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) Insmed, Inc. (INSM) GRAIL, Inc. Common Stock (GRAL) GSK plc (GSK) IDEAYA Biosciences, Inc. Common Stock (IDYA) MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) One Cash (ONC) Axsome Therapeutics, Inc (AXSM) United Community Banks, Inc. (UCB) Prometheus Biosciences, Inc. Common Stock (RXDX) Wave Life Sciences Ltd. Ordinary Shares (WVE) Royalty Pharma plc Class A Ordinary Shares (RPRX) Neurocrine Biosciences, Inc. (NBIX) Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Sanofi (SNY) Rhythm Pharmaceuticals, Inc. Common Stock (RYTM) Celcuity Inc. Common Stock (CELC) Baklava (BAVA)
Top posts by engagements in the last XX hours
"$NBIX Reports Third Quarter 2025 Financial Results. CRENESSITY (crinecerfont) Third-Quarter 2025 Net Product Sales of $98M"
X Link 2025-10-28T20:10Z 5924 followers, 1209 engagements
"$VRTX $ALPN Presents Updated Phase 1/2 Data From RUBY-3 Study That Continue to Demonstrate Best-in-Class Potential for Povetacicept in Adults with IgA Nephropathy and Primary Membranous Nephropathy at ASN Kidney Week. $NVS #Otsuka"
X Link 2025-11-09T10:55Z 5924 followers, 5624 engagements
"$SGEN ($43B) $ARNA ($7B) $GBT ($5B) $ARRY ($11B) $MTSR ($8B upfront) $TRIL ($2B) $MDVN ($14B) $BHVN ($12B) = $102B. $PFE market cap: $144B"
X Link 2025-11-18T15:25Z 5924 followers, 131.2K engagements
"$BPMC a $SNY Company Highlights Long-Term Clinical Benefit of AYVAKIT (avapritinib) Across Indolent and Advanced Systemic Mastocytosis at 2025 ASH Annual Meeting. $COGT"
X Link 2025-12-05T13:06Z 5922 followers, 4379 engagements
"$SMMT $500M PIPE @ $18.74$ per share. $AZN Summit Co-CEO and Executive Chairman Robert Duggan Co-CEO and President Mahkam Zanganeh CFO and COO Manmeet Soni CAO Bhaskar Anand and certain non-executive employees invested $272M; Akeso invested $10M remaining $218M raised with multiple leading biopharma institutional investors and other institutional investors"
X Link 2025-10-22T12:24Z 5922 followers, 9023 engagements
"#Eisai Submits New Drug Application for Subcutaneous Formulation of Leqembi for the Treatment of Early Alzheimers Disease in Japan. $BIIB $BIOA.ST"
X Link 2025-11-28T07:08Z 5922 followers, 1862 engagements
"Exclusive: I met Jennifer Ruddock CBO of $NKTR at BIO Europe in Vienna. Read the interview (Part 1) 👇 $LLY"
X Link 2025-11-30T09:16Z 5922 followers, 9472 engagements
"$SGMO Receives U.S. FDA Fast Track Designation for ST-503 for the Treatment of Small Fiber Neuropathy"
X Link 2025-12-02T13:11Z 5924 followers, 2258 engagements
"Baker Bros are not always right but I consider them to be among the top investors in the biotech scene. Many very successful stocks and M&A candidates with high weighting. 👇 $MDGL $INSM $RYTM $RVMD $CELC $GRAL $ABVX $ARWR"
X Link 2025-12-04T09:38Z 5922 followers, 7324 engagements
"$GSK GSK terminates collaboration agreement with $IDYA"
X Link 2025-12-06T06:56Z 5922 followers, 8522 engagements
"$COGT Presents Full SUMMIT Results ofBezuclastinibinPatientswithNonAdvancedSystemic Mastocytosis (NonAdvSM)at the67thAnnual Meeting of the American Society of Hematology (ASH) $BPMC $SNY"
X Link 2025-12-06T18:00Z 5922 followers, 8584 engagements
"$GUBRA #BoehringerIngelheim advances next generation triple-agonist peptide for the treatment of obesity into mid-stage development. $LLY $NVO $VKTX $ABBV"
X Link 2025-12-08T07:05Z 5922 followers, 1344 engagements
"$TSHA Regains Full Rights to Lead TSHA-102 Program in Clinical Evaluation for the Treatment of Rett Syndrome. #Astellas"
X Link 2025-10-16T20:03Z 5924 followers, 11.9K engagements
"$GALD #Galderma Delivers Record Net Sales of XXXXX Billion USD in the First Nine Months of 2025 and XXXX% Year-on-Year Growth at Constant Currency Raises Full-Year Guidance"
X Link 2025-10-23T05:04Z 5924 followers, 1070 engagements
"$KYMR Presents New Preclinical Data for KT-579 a First-in-Class Oral IRF5 Degrader at the American College of Rheumatology Annual Meeting"
X Link 2025-10-27T11:02Z 5924 followers, 4515 engagements
"$KYTX nnounces Positive Interim Phase X Data from KYSA-6 Study of KYV-101 in Generalized Myasthenia Gravis at AANEM 2025. $ARGX $JNJ"
X Link 2025-10-29T10:33Z 5924 followers, 1051 engagements
"$BAVA $BAVA.CO Bavarian Nordic Awarded New Procurement Framework Contract by the European Commission to Strengthen Preparedness Against Smallpox and Mpox"
X Link 2025-10-31T08:43Z 5923 followers, 1006 engagements
"$SNY Q3 call transcript $ABVX"
X Link 2025-10-31T10:00Z 5920 followers, 10.5K engagements
"$SMMT Akeso's Ivonescimab Secures Fourth Breakthrough Therapy Designation in China for First-Line Treatment of Triple-Negative Breast Cancer"
X Link 2025-11-03T06:21Z 5923 followers, 1972 engagements
"#Sandoz boosts in-house biosimilars capabilities by signing agreement to acquire Just-Evotec Biologics EU SAS in Toulouse. Transaction includes $350M in cash and upfront license fees. JEB partnered projects below. $SDZ $EVT"
X Link 2025-11-05T07:00Z 5923 followers, 1131 engagements
"$MLTX Reports Third Quarter 2025 Financial Results and Announces New Data from Clinical Trials of its Nanobody Sonelokimab"
X Link 2025-11-05T12:08Z 5920 followers, XXX engagements
"$CAI Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance"
X Link 2025-11-05T21:06Z 5924 followers, 1255 engagements
"$ONC Q3 results. Third quarter total revenues increased XX% to $1.4B"
X Link 2025-11-06T11:03Z 5921 followers, 1058 engagements
"$AXSM Acquires Subtype Selective GABA-A Receptor Positive Allosteric Modulator AZD7325 for the Treatment of Epilepsy"
X Link 2025-11-06T12:12Z 5920 followers, 1716 engagements
"$PTGX PN-881 entered the clinical stage. First human subject dosed in a Phase X trial in October"
X Link 2025-11-07T10:07Z 5923 followers, 3308 engagements
"$CRNX pipeline. $1.1B Cash Balance Funds Current Operating Plan into 2029. Market cap: $4B. The focus is now on the commercial roll-out of Palsonify. $CAMX"
X Link 2025-11-07T10:16Z 5924 followers, 8986 engagements
"@PersimmonTI @Biohazard3737 Winning overpriced M&A transactions. $GBT $TRIL $ARNA $SGEN $ARRY"
X Link 2025-11-08T16:44Z 5922 followers, XXX engagements
"An approval for Povetacicept (formerly ALPN-303) would also be a success for German based #Evotec. They have a multi-year partnership with $ALPN which was acquired by $VRTX for $4.9B in 2024"
X Link 2025-11-09T11:45Z 5923 followers, 3962 engagements
"$COGT Reports Positive Results from Bezuclastinib PEAK Phase X Trial in Gastrointestinal Stromal Tumors (GIST). $BPMC $SNY $DCPH"
X Link 2025-11-10T12:01Z 5922 followers, 17.3K engagements
"$IFRX Reports Positive Phase 2a Data for INF904 in Hidradenitis Suppurative (HS) and Chronic Spontaneous Urticaria (CSU). $UCB $MLTX $CLDX"
X Link 2025-11-10T12:32Z 5920 followers, 1554 engagements
"$CYTK Presents Additional Data from MAPLE-HCM at the Hypertrophic Cardiomyopathy Medical Society Scientific Sessions and American Heart Association Scientific Sessions 2025. $BMY"
X Link 2025-11-10T12:33Z 5921 followers, 7125 engagements
"$RLMD should receive more attention here. Small position. $ENGN $CGON"
X Link 2025-11-11T14:58Z 5924 followers, 7674 engagements
"$EVT #Evotecreceives milestone payment from $BMY Bristol Myers Squibb following IND acceptance in strategic protein degradation partnership. $5M to Evotec"
X Link 2025-11-12T06:43Z 5923 followers, 1251 engagements
"$LEGN Q3 results. Carvykti net trade sales of approximately $524M. $JNJ"
X Link 2025-11-12T12:04Z 5924 followers, XXX engagements
"$ZEAL Announces Financial Results for the First Nine Months of 2025. 2.2B cash"
X Link 2025-11-13T06:49Z 5923 followers, 3047 engagements
"$DAWN to Acquire $MRSN - $XX per share + CVR"
X Link 2025-11-13T12:59Z 5924 followers, 1169 engagements
"$ONC Positive Phase X Results Support ZIIHERA as HER2-Targeted Therapy-of-Choice and Combination with TEVIMBRA and Chemotherapy as New Standard of Care in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma $JAZZ $ZYME"
X Link 2025-11-17T11:03Z 5924 followers, 3305 engagements
"$MRUS and $HALO Enter Global Collaboration and License Agreement to Develop Subcutaneous Formulation of Petosemtamab"
X Link 2025-11-17T12:40Z 5921 followers, 1678 engagements
"$ABVX now $9B market cap after successful UC phase X. Keep in mind: $MRK acquired $RXDX for $10.8B after a successful phase 2"
X Link 2025-11-17T14:44Z 5921 followers, 15.9K engagements
"$PTGX $JNJ $TAK"
X Link 2025-11-18T12:56Z 5921 followers, 3696 engagements
"$NUVL Announces Pricing of Public Offering of Common Stock - $XXXXXX per share"
X Link 2025-11-19T06:10Z 5921 followers, XXX engagements
"$ARWR the US approval of REDEMPLO is just the beginning. XX clinical stage programs (10 wholly-owned; X partnered) - more to come. Strong comeback: share price has quadrupled from its low for the year. $NVS $SRPT $AMGN $GSK $TAK"
X Link 2025-11-19T08:52Z 5923 followers, 5799 engagements
"$AGIO Announces Topline Results from RISE UP Phase X Trial of Mitapivat in Sickle Cell Disease. $CRSP $VRTX"
X Link 2025-11-19T12:03Z 5924 followers, 3201 engagements
"$RNA Announces U.S. Managed Access Program (MAP) for Investigational Therapy del-zota in DMD44. $NVS $SRPT"
X Link 2025-11-19T14:18Z 5924 followers, 2654 engagements
"$ABVX $10B now. Keep in mind: $MRK paid for $RXDX $10.8B after a successful phase 2"
X Link 2025-11-20T16:35Z 5921 followers, 5989 engagements
"$CRNX Announces First Patient Randomized in Pivotal Phase X CAREFNDR Trial Evaluating Paltusotine in Carcinoid Syndrome"
X Link 2025-11-21T06:59Z 5922 followers, 1288 engagements
"$GEHC to acquire Intelerad advancing cloud-enabled enterprise imaging across care settings for $2.3B. #Sectra $SECTRA"
X Link 2025-11-21T07:56Z 5923 followers, 1234 engagements
"$VSTM upcoming catalysts. Impressive strength after the latest offering last week ($90M at $XXXX per share). $XX area key resistance. $RVMD"
X Link 2025-11-21T11:17Z 5923 followers, 4523 engagements
"$ARWR Earns $XXX Million Milestone Payment from $SRPT"
X Link 2025-11-24T13:47Z 5923 followers, 5987 engagements
"$BIIB and Dayra Therapeutics Announce Research Collaboration to Discover and Develop Oral Macrocyclic Peptides for a Range of Immunological Conditions"
X Link 2025-11-24T16:13Z 5923 followers, 1415 engagements
"$REGN $SNY Dupixent (dupilumab) Approved as the First Targeted Medicine in the European Union (EU) in Over a Decade for Chronic Spontaneous Urticaria (CSU). $CLDX"
X Link 2025-11-25T06:46Z 5923 followers, 12.2K engagements
"$ABVX $RVMD $PTGX trading like a buyout announcement is imminent. Incredible strength"
X Link 2025-11-26T10:38Z 5923 followers, 7577 engagements
"#Otsuka Receives FDA Accelerated Approval for VOYXACT (sibeprenlimab-szsi) for the Reduction of Proteinuria in Adults with Primary Immunoglobulin A Nephropathy (IgAN) at Risk for Disease Progression. $VRTX $NVS $TVTX"
X Link 2025-11-26T12:03Z 5922 followers, 1404 engagements
"$ARWR patience pays off. What an impressive recovery from $XX - the stock was my favorite for the year 2025"
X Link 2025-11-26T12:34Z 5921 followers, 4076 engagements
"$ARWR $XX. As I wrote at the end of 2024: 2025 is a year with many interesting inflection points + unlocking obesity fantasy/potential"
X Link 2025-11-26T15:55Z 5923 followers, 6910 engagements
"$MDGL $XXX 💥"
X Link 2025-11-26T16:51Z 5920 followers, XXX engagements
"$VSTM $XXXXX - strength continues after the offering. $RVMD"
X Link 2025-11-26T19:11Z 5923 followers, 2157 engagements
"From injections to pills: oral peptides set to transform drug development (August 2025). $PTGX $JNJ $MRK"
X Link 2025-11-27T09:33Z 5923 followers, 4047 engagements
"$PTGX TD Cowen Advancements in #Obesity Summit. Some interesting comments. $LLY $NVO"
X Link 2025-11-27T15:01Z 5921 followers, 3316 engagements
"$ABBV SKYRIZI (risankizumab) Receives Positive Reimbursement Recommendation by Canadas Drug Agency for Ulcerative Colitis and AbbVie Concludes Letter of Intent with the pan-Canadian Pharmaceutical Alliance"
X Link 2025-11-28T12:10Z 5923 followers, 1231 engagements
"$IONS receives U.S. FDA Breakthrough Therapy designation for olezarsen for severe hypertriglyceridemia (sHTG)"
X Link 2025-12-01T12:01Z 5921 followers, 1805 engagements
"$REGN and Tessera Therapeutics to Jointly Develop TSRA-196 an Investigational Gene Editing Therapy for Alpha-1 Antitrypsin Deficiency (#AATD)"
X Link 2025-12-01T12:01Z 5923 followers, 1264 engagements
"$LLY lowers the price of Zepbound (tirzepatide) single-dose vials. $NVO"
X Link 2025-12-01T13:32Z 5923 followers, 2217 engagements
"$AZN #Astrazeneca Baxdrostat New Drug Application accepted under FDA Priority Review in the US for patients with hard-to-control hypertension. PDUFA date is anticipated during the second quarter of 2026 following use of a Priority Review voucher. $MLYS"
X Link 2025-12-02T08:09Z 5924 followers, 1486 engagements
"$VTYX Provides Clinical and Corporate Updates"
X Link 2025-12-02T12:03Z 5922 followers, 1538 engagements
"$CLDX strength up X% after $JSPR asthma data"
X Link 2025-12-02T17:09Z 5922 followers, 2193 engagements
"$PHVS $RPRX"
X Link 2025-12-03T11:57Z 5923 followers, 1764 engagements
"After $JNJ and $NVO failures: $BMY Announces Continuation of ADEPT-2 Phase X Study in Psychosis Associated with Alzheimer's Disease"
X Link 2025-12-03T12:08Z 5922 followers, 4164 engagements
"$CRNX next step 👍"
X Link 2025-12-03T13:11Z 5922 followers, 2279 engagements
"$CRNX break. Next target $60"
X Link 2025-12-03T15:22Z 5922 followers, 1979 engagements
"Interesting. $ABBV already partnered with $GUBRA (amylin) this year. Who's next $LLY $NVO $VKTX $GPCR"
X Link 2025-12-03T16:44Z 5923 followers, 7130 engagements
"$DNLI and $RPRX Announce $XXX Million Royalty Funding Agreement"
X Link 2025-12-04T12:02Z 5924 followers, 4395 engagements
"What else can $ABBV say Rinvoq and Skyrizi are THE growth drivers in the portfolio following the Humira patent cliff. Competition is not welcome here - I can imagine that AbbVie will purchase/license further assets in this area and in the field of obesity. $ABVX $GUBRA"
X Link 2025-12-04T14:48Z 5923 followers, 2874 engagements
"$PRAX Announces Positive Pre-NDA Meeting with FDA for Ulixacaltamide in Essential Tremor"
X Link 2025-12-04T21:04Z 5921 followers, 2052 engagements
"IDE034 a Bispecific #ADC Licensed by Biocytogen to $IDYA Receives FDA IND Clearance"
X Link 2025-12-05T07:09Z 5922 followers, 1201 engagements
"$NTRA Acquires #Foresight Diagnostics - all-stock transaction consisting of a $XXX million upfront with an additional $XXX million in earnouts tied to the achievement of revenue- and reimbursement-based milestones"
X Link 2025-12-05T12:08Z 5923 followers, 1688 engagements
"$VKTX interesting price action yesterday. New FDA guidelines could make an additional phase X for VK2735 obsolete. The stock must break through the $XX area. Then there is plenty of room for more gains"
X Link 2025-12-05T12:33Z 5923 followers, 8733 engagements
"$CLDX 52-week high yesterday. The bulls are finally waking up. 2026 will be an extremely important year for Celldex. Small position"
X Link 2025-12-05T12:38Z 5922 followers, XXX engagements
"The "robots are on the move" see $IRBT. I'm wondering why $BB hasn't jumped yet. But it could still happen. Current share price: $XXXX #QNX #Robotics @Reddit"
X Link 2025-12-05T13:45Z 5924 followers, 1868 engagements
"$PTGX strength into the weekend. Deal close $JNJ $TAK"
X Link 2025-12-05T20:00Z 5924 followers, 2856 engagements
"OSE Immunotherapeutics Announces Strategic Amendment to AbbVies Partnership on ABBV-230 Development. $ABBV"
X Link 2025-12-08T06:35Z 5923 followers, 1389 engagements
"$AXSM new ATH - interesting potential buyout target. $BPMC $ITCI $VRNA and $SWTX gone (see list below)"
X Link 2025-11-12T15:32Z 5924 followers, 3886 engagements
"What would $PTGX be worth if Icotrokinra and Rusfertide weren't partnered In my opinion $PTGX could be in the range of $INSM in terms of market cap in some years. Large markets ingenious technology (oral). What pharma wants - easily available"
X Link 2025-11-20T14:01Z 5922 followers, 8584 engagements
"$KYMR data in December. Barclays comment below. $NKTR $REGN $SNY $CRVS"
X Link 2025-12-01T06:53Z 5924 followers, 4925 engagements
"$CRVS additional data in January Barclays comment below. $NKTR $KYMR $SNY $REGN"
X Link 2025-12-01T06:53Z 5923 followers, 8298 engagements
"$CAPR Announces Positive Topline Results from Pivotal Phase X HOPE-3 Study of Deramiocel in Duchenne Muscular Dystrophy. $SRPT"
X Link 2025-12-03T12:36Z 5924 followers, 2661 engagements
"$PTGX and $TAK Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera"
X Link 2025-12-06T17:56Z 5922 followers, 1448 engagements
"$GPCR $WVE $KYMR and $DYN data ahead - busy #biotech Monday. Maybe also a M&A deal $PTGX $RVMD $ABVX"
X Link 2025-12-08T07:52Z 5922 followers, 7804 engagements
"$PCSC Freenome and Perceptive Capital Solutions Corp Announce Business Combination Agreement to Create a Publicly Listed Company Transforming Blood-Based Multi-Cancer Detection through an AI/ML-Enabled Multiomics Platform. $GRAL $ILMN $EXAS"
X Link 2025-12-05T13:53Z 5922 followers, 2181 engagements
"$GMAB Announces Data From Multiple Clinical Trials Showing Treatment with Fixed-Duration Epcoritamab Led to Remissions in First-Line Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL)"
X Link 2025-12-06T17:57Z 5924 followers, 2379 engagements
"$ZLAB Announces Updates to Chinas National Reimbursement Drug List"
X Link 2025-12-07T09:57Z 5922 followers, 1533 engagements
"Wow: LORAL GROUPE TO REINFORCE ITS STRATEGIC INVESTMENT IN #GALDERMA WITH AN ADDITIONAL XX% BRINGING ITS TOTAL PARTICIPATION TO 20%"
X Link 2025-12-08T06:36Z 5922 followers, 3141 engagements
"Greetings from #DisneylandParis - I hope for a French #biotech buyout soon 😉 Strong day for $ABVX 💪"
X Link 2025-12-09T22:23Z 5922 followers, 2563 engagements
/creator/x::doepke_michel